GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » Price-to-Operating-Cash-Flow

Huaren Pharmaceutical Co (SZSE:300110) Price-to-Operating-Cash-Flow : 11.15 (As of Jun. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-06-04), Huaren Pharmaceutical Co's share price is ¥3.30. Huaren Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.30. Hence, Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 11.15.

The historical rank and industry rank for Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:300110' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.04   Med: 31.25   Max: 908.33
Current: 11.14

During the past 13 years, Huaren Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 908.33. The lowest was 11.04. And the median was 31.25.

SZSE:300110's Price-to-Operating-Cash-Flow is ranked better than
67.74% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.205 vs SZSE:300110: 11.14

Huaren Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.30.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Huaren Pharmaceutical Co was 24.40% per year.

During the past 13 years, Huaren Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 139.90% per year. The lowest was -43.30% per year. And the median was 21.25% per year.


Huaren Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huaren Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Huaren Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.92 - - 23.04 16.36

Huaren Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 15.44 15.98 16.36 12.09

Competitive Comparison of Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Huaren Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3.30/0.296
=11.15

Huaren Pharmaceutical Co's Share Price of today is ¥3.30.
Huaren Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Huaren Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Huaren Pharmaceutical Co (SZSE:300110) Business Description

Traded in Other Exchanges
N/A
Address
No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
Executives
Yang Xiao Dong Director
Bo Guo Xiu Executives
Zhou Xi Jian Director
Mao Yu Wei Supervisors
Chu Xiao Jun Executives
Zhou Qiang Directors, executives
Ji Sheng Bin Executives
Xiao Wei Wen Executives
Shen Hong Ce Executives
Li Xiao Li Executives
Liu Qian Executives
Wang Wen Ping Executives
Liang Fu You Director
Liang Fu Dong Director
Gong Ling Secretary Dong

Huaren Pharmaceutical Co (SZSE:300110) Headlines

No Headlines